BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25689223)

  • 1. RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT Mice.
    Shimizu S; Ringpis GE; Marsden MD; Cortado RV; Wilhalme HM; Elashoff D; Zack JA; Chen IS; An DS
    Mol Ther Nucleic Acids; 2015 Feb; 4(2):e227. PubMed ID: 25689223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice.
    Ringpis GE; Shimizu S; Arokium H; Camba-Colón J; Carroll MV; Cortado R; Xie Y; Kim PY; Sahakyan A; Lowe EL; Narukawa M; Kandarian FN; Burke BP; Symonds GP; An DS; Chen IS; Kamata M
    PLoS One; 2012; 7(12):e53492. PubMed ID: 23300932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model.
    Shimizu S; Hong P; Arumugam B; Pokomo L; Boyer J; Koizumi N; Kittipongdaja P; Chen A; Bristol G; Galic Z; Zack JA; Yang O; Chen IS; Lee B; An DS
    Blood; 2010 Feb; 115(8):1534-44. PubMed ID: 20018916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector.
    Burke BP; Levin BR; Zhang J; Sahakyan A; Boyer J; Carroll MV; Colón JC; Keech N; Rezek V; Bristol G; Eggers E; Cortado R; Boyd MP; Impey H; Shimizu S; Lowe EL; Ringpis GE; Kim SG; Vatakis DN; Breton LR; Bartlett JS; Chen IS; Kitchen SG; An DS; Symonds GP
    Mol Ther Nucleic Acids; 2015 Apr; 4():e236. PubMed ID: 25872029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
    Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo selection of anti-HIV-1 gene-modified human hematopoietic stem/progenitor cells to enhance engraftment and HIV-1 inhibition.
    Guo Q; Zhang J; Parikh K; Brinkley A; Lin S; Zakarian C; Pernet O; Shimizu S; Khamaikawin W; Hacke K; Kasahara N; An DS
    Mol Ther; 2024 Feb; 32(2):384-394. PubMed ID: 38087779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.
    Myburgh R; Ivic S; Pepper MS; Gers-Huber G; Li D; Audigé A; Rochat MA; Jaquet V; Regenass S; Manz MG; Salmon P; Krause KH; Speck RF
    J Virol; 2015 Jul; 89(13):6761-72. PubMed ID: 25903342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4
    Xiao Q; Chen S; Wang Q; Liu Z; Liu S; Deng H; Hou W; Wu D; Xiong Y; Li J; Guo D
    Retrovirology; 2019 Jun; 16(1):15. PubMed ID: 31186067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor.
    Wolstein O; Boyd M; Millington M; Impey H; Boyer J; Howe A; Delebecque F; Cornetta K; Rothe M; Baum C; Nicolson T; Koldej R; Zhang J; Keech N; Camba Colón J; Breton L; Bartlett J; An DS; Chen IS; Burke B; Symonds GP
    Mol Ther Methods Clin Dev; 2014; 1():11. PubMed ID: 26015947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional gene silencing limits CXCR4-associated depletion of bone marrow CD34+ cells in HIV-1 infection.
    Tsukamoto T
    AIDS; 2018 Aug; 32(13):1737-1747. PubMed ID: 29762163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector.
    Walker JE; Chen RX; McGee J; Nacey C; Pollard RB; Abedi M; Bauer G; Nolta JA; Anderson JS
    J Virol; 2012 May; 86(10):5719-29. PubMed ID: 22398281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivo.
    Sato K; Misawa N; Iwami S; Satou Y; Matsuoka M; Ishizaka Y; Ito M; Aihara K; An DS; Koyanagi Y
    PLoS Pathog; 2013; 9(12):e1003812. PubMed ID: 24339781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-Delivered Entry Inhibitors for HIV-1: CCR5 Downregulation and Blocking Virus/Membrane Fusion in Defending the Host Cell Population.
    Symonds G; Bartlett JS; Kiem HP; Tsie M; Breton L
    AIDS Patient Care STDS; 2016 Dec; 30(12):545-550. PubMed ID: 27905841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
    Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
    Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling Anti-HIV-1 HSPC-Based Gene Therapy in Humanized Mice Previously Infected with HIV-1.
    Khamaikawin W; Shimizu S; Kamata M; Cortado R; Jung Y; Lam J; Wen J; Kim P; Xie Y; Kim S; Arokium H; Presson AP; Chen ISY; An DS
    Mol Ther Methods Clin Dev; 2018 Jun; 9():23-32. PubMed ID: 29322065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo.
    Glushakova S; Yi Y; Grivel JC; Singh A; Schols D; De Clercq E; Collman RG; Margolis L
    J Clin Invest; 1999 Sep; 104(5):R7-R11. PubMed ID: 10487781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective infection of CD4+ effector memory T lymphocytes leads to preferential depletion of memory T lymphocytes in R5 HIV-1-infected humanized NOD/SCID/IL-2Rgammanull mice.
    Nie C; Sato K; Misawa N; Kitayama H; Fujino H; Hiramatsu H; Heike T; Nakahata T; Tanaka Y; Ito M; Koyanagi Y
    Virology; 2009 Nov; 394(1):64-72. PubMed ID: 19744686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 infection by a unique short hairpin RNA to chemokine receptor 5 delivered into macrophages through hematopoietic progenitor cell transduction.
    Liang M; Kamata M; Chen KN; Pariente N; An DS; Chen IS
    J Gene Med; 2010 Mar; 12(3):255-65. PubMed ID: 20186995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection.
    Yu S; Yao Y; Xiao H; Li J; Liu Q; Yang Y; Adah D; Lu J; Zhao S; Qin L; Chen X
    Hum Gene Ther; 2018 Jan; 29(1):51-67. PubMed ID: 28599597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector.
    Anderson J; Akkina R
    AIDS Res Ther; 2005 Jan; 2(1):1. PubMed ID: 15813990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.